Pharmaceutical Executive, June 2021 Issue (PDF)

Publication
Article
Pharmaceutical ExecutivePharmaceutical Executive-06-01-2021
Volume 41
Issue 6

Click the title above for a link to open the Pharmaceutical Executive June 2021 issue in an interactive PDF format.

Click cover to access PDF

Download Issue PDF
Articles in this issue
Three Ways to Overcome Any Market Challenge
Three Ways to Overcome Any Market Challenge
Staying the Course: Double Down on Launch Agility
Staying the Course: Double Down on Launch Agility
Betting on Its Base in Virology
Scientific Rigor, Urgent Action
Meeting the Crisis Head-On
Innovation in High Gear
Bonds Old and New to the Rescue
2021 Pharm Exec Top 50 Companies
2021 Pharm Exec Top 50 Companies
After Blowout 2020, Biotech Worst Performing Sector YTD
After Blowout 2020, Biotech Worst Performing Sector YTD
A Steward of Science
A Steward of Science
Product Analogs Point to Pricing and Distinct Payer Market Scenarios
Product Analogs Point to Pricing and Distinct Payer Market Scenarios
A Step Closer to 3D Printing for Personalized Medicines
A Step Closer to 3D Printing for Personalized Medicines
A Management Blueprint for Return to ‘Normal’
A Management Blueprint for Return to ‘Normal’
Bringing a European Focus to Drug Import Vulnerabilities
Bringing a European Focus to Drug Import Vulnerabilities
Pharma Prices and Patents Under Attack
Pharma Prices and Patents Under Attack
Recent Videos
Fred Aslan
Fred Aslan
Developing Non-Addictive Pain Medication
Related Content
Icotrokinra Demonstrates Promise in Moderate-to-Severe Plaque Psoriasis, Ulcerative Colitis

Icotrokinra Demonstrates Promise in Moderate-to-Severe Plaque Psoriasis, Ulcerative Colitis

Don Tracy, Associate Editor
March 11th 2025
Article

Results from multiple Phase III trials of Icotrokinra in moderate-to-severe plaque psoriasis and a Phase IIb trial in ulcerative colitis successfully met all primary endpoints.

Navigating Distrust: Pharma in the Age of Social Media

Navigating Distrust: Pharma in the Age of Social Media

Miranda Schmalfuhs
February 18th 2025
Podcast

Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.

Viking Therapeutics, CordenPharma Strike Multi-Year Deal to Commercialize VK2735 for Obesity, Metabolic Disorders

Viking Therapeutics, CordenPharma Strike Multi-Year Deal to Commercialize VK2735 for Obesity, Metabolic Disorders

Don Tracy, Associate Editor
March 11th 2025
Article

Partnership is expected to support Phase III development of VK2735 in patients with obesity and metabolic disorders amid increasing demand for GLP-1 therapy.

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs
February 10th 2025
Podcast

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.

Jennifer Butler

The Misinformation Maze: Navigating Public Health in the Digital Age

Miranda Schmalfuhs
March 11th 2025
Article

Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.

Pharma Pulse

Pharma Pulse 3/11/25: Strategic Trends in Pharmaceutical Manufacturing, The Power of 'Skinfluencers' & more

Miranda Schmalfuhs
March 11th 2025
Article

The latest news for pharma industry insiders.